Phillip Simmons

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia**A complete list of participants in the Research Group and Publication Committee appears in the Appendix.

Moti L. Kashyap, Mark E. McGovern, Kathleen Berra et al. · The American Journal of Cardiology · 2002 · 234 citations

Drug Safety, Cardiovascular Disease, Medicine +6

Treatment with 24 Hour Istaroxime Infusion in Patients Hospitalised for Acute Heart Failure: A Randomised, Placebo-Controlled Trial

Valentina Carubelli, Yuhui Zhang, Marco Metra et al. · European Journal of Heart Failure · 2020 · 62 citations

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study ( <scp>SEISMiC</scp> )

Marco Metra, Ovidiu Chioncel, Gad Cotter et al. · European Journal of Heart Failure · 2022 · 39 citations · Full text

A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure

Neal J. Thomas, Carlos Guardia, Fernando Moya et al. · Pediatric Critical Care Medicine · 2012 · 35 citations

Effectiveness of aggressive management of dyslipidemia in a collaborative-care practice model

Michael J. Ryan, Joan McIver Gibson, Phillip Simmons et al. · The American Journal of Cardiology · 2003 · 14 citations

Family Medicine, Disease Management, Integrated Care +12